September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Risk factors and the incidence of patients with diabetic retinopathy in patients of Eyes Institute of Goiânia; Goiânia - Go
Author Affiliations & Notes
  • DENISE Borges de Andrade Mendanha
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • mateus martins cortez vilar
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • Joao J Nassaralla
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • Luana MIRANDA CAMPOS
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • Mayara Martins Abrahao
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • Leonardo Pinheiro Teixeira
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • Eduardo Dalia
    Instituto de Olhos de Goiânia , Goianiaa, Brazil
  • Footnotes
    Commercial Relationships   DENISE Borges de Andrade Mendanha, None; mateus martins cortez vilar, None; Joao Nassaralla, None; Luana CAMPOS, None; Mayara Martins Abrahao, None; Leonardo Pinheiro Teixeira, None; Eduardo Dalia, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1603. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      DENISE Borges de Andrade Mendanha, mateus martins cortez vilar, Joao J Nassaralla, Luana MIRANDA CAMPOS, Mayara Martins Abrahao, Leonardo Pinheiro Teixeira, Eduardo Dalia; Risk factors and the incidence of patients with diabetic retinopathy in patients of Eyes Institute of Goiânia; Goiânia - Go. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1603.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : One of the major microvascular complications of diabetes, and diabetic retinopathy (DR), which is the main cause of blindness among North Americans between the ages 20 to 64, causing 8,000 new cases of blindness each year(2). The duration of DM is strongly associated with the frequency and severity of DR (11). According to Kullberg and Arnqvist with the introduction of glycated hemoglobin, it was demonstrated that the blood glucose control is the most important independent risk factor for diabetic retinopathy(12). On the other hand, the Hypertension Systemic is twice as common in people with diabetes, and appears to make an important role in diabetic retinopathy.

The present study aims to evaluate the incidence and risk factors of diabetic retinopathy (disease duration and the presence of hypertension) in patients with diabetic retinopathy diagnosed in the retina sector of a reference ophthalmological hospital in Goiânia-Go, from November 2015 to May 2016.

Methods : This is a field study, transversal, quantitative approach. The study population will be patients diagnosed with diabetic retinopathy met in November 2015 to May 2016. As a data collection instrument of patients will be through analysis of medical records, will be lifted the following data: time of diagnosis of diabetes mellitus, presence or absence of systemic hypertension, gender, age and visual acuity beyond the established conduct after evaluation of the patient. The data collected will be analyzed by the researchers. Will be evaluated the relationship of the disease with sex, age, estimated time of diagnosis, type of diabetes and retinopathy, clinical presence of hypertension, visual acuity.

Results : The overall incidence of diabetic retinopathy was 72 new cases in the six months of analysis. Of which a total of 70% had systemic arterial hypertension and 70% had inefficient glycemic control. It was observed that 75% of the patients had diabetes for over 20 years and among those, 80% had laser photocoagulation indication.

Conclusions : There was a strong relationship between severe diabetic retinopathy, as well as the duration of disease, with a poor outcome. Thus it is demonstrated that pressure, and duration of disease correlate with a poor retinal injury frame, when compared to the patients with good glycemic control, and reduced disease duration.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×